ILARIS®

(Canakinumab)

Documentation

Patented
Approved 2009
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: IL-1b
Indication Category: Other

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA